KlyneAI
Klyne is a JLABS company focused on next-generation binding affinity models for drug discovery. They provide AI-powered tools for hit identification and optimization, making virtual screening accessible to startups and academic labs at a fraction of the cost. Their proprietary machine learning models enhance computational efficiency, allowing for the screening of billions of compounds while significantly reducing false positives and costs. Klyne's mission is to democratize access to advanced molecular predictions, ensuring that all companies can benefit from their innovative solutions.
KlyneAI
Klyne is a JLABS company focused on next-generation binding affinity models for drug discovery. They provide AI-powered tools for hit identification and optimization, making virtual screening accessible to startups and academic labs at a fraction of the cost. Their proprietary machine learning models enhance computational efficiency, allowing for the screening of billions of compounds while significantly reducing false positives and costs. Klyne's mission is to democratize access to advanced molecular predictions, ensuring that all companies can benefit from their innovative solutions.